866-997-4948(US-Canada Toll Free)

Global Biosimilars Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 117 Pages

This report studies the global market size of Biosimilars in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biosimilars in these regions.
This research report categorizes the global Biosimilars market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Biosimilars market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Biosimilars market based on company, product type, application and key regions.

The various contributors involved in the value chain of Biosimilars include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Biosimilars include
Pfizer
Sandoz International GmbH
Teva Pharmaceuticals Industries
Amgen Inc
Biocon
Dr. Reddys Laboratories
F. Hoffmann-La Roche
Celltrion
Samsung Bioepis

Market Size Split by Type
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Peptides (Glucagon, Calcitonin)
Market Size Split by Application
Oncology
Blood Disorders

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Biosimilars market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Biosimilars market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biosimilars manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Biosimilars submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biosimilars are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biosimilars market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Biosimilars Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Biosimilars Market Size Growth Rate by Type
1.4.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.4.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.4.4 Peptides (Glucagon, Calcitonin)
1.5 Market by Application
1.5.1 Global Biosimilars Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Blood Disorders
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Biosimilars Market Size
2.1.1 Global Biosimilars Revenue 2016-2025
2.1.2 Global Biosimilars Sales 2016-2025
2.2 Biosimilars Growth Rate by Regions
2.2.1 Global Biosimilars Sales by Regions
2.2.2 Global Biosimilars Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Biosimilars Sales by Manufacturers
3.1.1 Biosimilars Sales by Manufacturers
3.1.2 Biosimilars Sales Market Share by Manufacturers
3.1.3 Global Biosimilars Market Concentration Ratio (CR5 and HHI)
3.2 Biosimilars Revenue by Manufacturers
3.2.1 Biosimilars Revenue by Manufacturers (2016-2018)
3.2.2 Biosimilars Revenue Share by Manufacturers (2016-2018)
3.3 Biosimilars Price by Manufacturers
3.4 Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilars Product Category
3.4.3 Date of International Manufacturers Enter into Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Biosimilars Sales by Type
4.2 Global Biosimilars Revenue by Type
4.3 Biosimilars Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Biosimilars Breakdown Data by Application

6 North America
6.1 North America Biosimilars by Countries
6.1.1 North America Biosimilars Sales by Countries
6.1.2 North America Biosimilars Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Biosimilars by Type
6.3 North America Biosimilars by Application
6.4 North America Biosimilars by Company

7 Europe
7.1 Europe Biosimilars by Countries
7.1.1 Europe Biosimilars Sales by Countries
7.1.2 Europe Biosimilars Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biosimilars by Type
7.3 Europe Biosimilars by Application
7.4 Europe Biosimilars by Company

8 Asia Pacific
8.1 Asia Pacific Biosimilars by Countries
8.1.1 Asia Pacific Biosimilars Sales by Countries
8.1.2 Asia Pacific Biosimilars Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Biosimilars by Type
8.3 Asia Pacific Biosimilars by Application
8.4 Asia Pacific Biosimilars by Company

9 Central & South America
9.1 Central & South America Biosimilars by Countries
9.1.1 Central & South America Biosimilars Sales by Countries
9.1.2 Central & South America Biosimilars Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Biosimilars by Type
9.3 Central & South America Biosimilars by Application
9.4 Central & South America Biosimilars by Company

10 Middle East and Africa
10.1 Middle East and Africa Biosimilars by Countries
10.1.1 Middle East and Africa Biosimilars Sales by Countries
10.1.2 Middle East and Africa Biosimilars Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Biosimilars by Type
10.3 Middle East and Africa Biosimilars by Application
10.4 Middle East and Africa Biosimilars by Company

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Biosimilars
11.1.4 Biosimilars Product Description
11.1.5 Recent Development
11.2 Sandoz International GmbH
11.2.1 Sandoz International GmbH Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Biosimilars
11.2.4 Biosimilars Product Description
11.2.5 Recent Development
11.3 Teva Pharmaceuticals Industries
11.3.1 Teva Pharmaceuticals Industries Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Biosimilars
11.3.4 Biosimilars Product Description
11.3.5 Recent Development
11.4 Amgen Inc
11.4.1 Amgen Inc Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Biosimilars
11.4.4 Biosimilars Product Description
11.4.5 Recent Development
11.5 Biocon
11.5.1 Biocon Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Biosimilars
11.5.4 Biosimilars Product Description
11.5.5 Recent Development
11.6 Dr. Reddys Laboratories
11.6.1 Dr. Reddys Laboratories Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Biosimilars
11.6.4 Biosimilars Product Description
11.6.5 Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Biosimilars
11.7.4 Biosimilars Product Description
11.7.5 Recent Development
11.8 Celltrion
11.8.1 Celltrion Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Biosimilars
11.8.4 Biosimilars Product Description
11.8.5 Recent Development
11.9 Samsung Bioepis
11.9.1 Samsung Bioepis Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Biosimilars
11.9.4 Biosimilars Product Description
11.9.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Biosimilars Raw Material
13.1.2 Biosimilars Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Biosimilars
Figure Global Biosimilars Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Biosimilars Production Market Share by Types (Product Category) in 2017
Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Table Major Manufacturers of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Product Picture
Table Major Manufacturers of Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Figure Peptides (Glucagon, Calcitonin) Product Picture
Table Major Manufacturers of Peptides (Glucagon, Calcitonin)
Table Global Biosimilars Market Size Growth Rate by Application 2018-2025 (K MT)
Figure Oncology
Figure Blood Disorders
Figure Biosimilars Report Years Considered
Figure Global Biosimilars Market Size 2016-2025 (Million US$)
Figure Global Biosimilars Sales 2016-2025 (K MT)
Table Global Biosimilars Market Size by Regions 2016-2025 (K MT) & (Million US$)
Table Global Biosimilars Sales by Regions 2016-2025 (K MT)
Table Global Biosimilars Sales Market Share by Regions 2016-2025
Figure Global Biosimilars Sales Market Share by Regions 2016-2025
Figure 2017 Global Biosimilars Sales Market Share by Regions
Table Global Biosimilars Revenue by Regions 2016-2025 (Million US$)
Table Global Biosimilars Revenue Market Share by Regions 2016-2025
Figure Global Biosimilars Revenue Market Share by Regions 2016-2025
Figure 2017 Global Biosimilars Revenue Market Share by Regions
Table Global Biosimilars Sales by Manufacturers (2016-2018) (K MT)
Table Global Biosimilars Sales Share by Manufacturers (2016-2018)
Figure Global Biosimilars Sales Share by Manufacturers in 2017
Table Biosimilars Revenue by Manufacturers (2016-2018) (Million US$)
Table Biosimilars Revenue Share by Manufacturers (2016-2018)
Figure Biosimilars Value Share by Manufacturers in 2017
Table Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Biosimilars Price (2016-2018) (USD/MT)
Table Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Biosimilars Product Category
Table Date of International Manufacturers Enter into Biosimilars Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Biosimilars Sales by Type (2016-2025) (K MT)
Table Global Biosimilars Sales Share by Type (2016-2025)
Figure Global Biosimilars Sales Market Share by Type (2016-2025)
Figure Global Biosimilars Sales Market Share by Type in 2017
Table Global Biosimilars Revenue by Type (2016-2025) (Million US$)
Table Global Biosimilars Revenue Share by Type (2016-2025)
Figure Global Biosimilars Revenue Market Share by Type (2016-2025)
Figure Global Biosimilars Revenue Market Share by Type in 2017
Table Biosimilars Price by Type 2013-2018 (USD/MT)
Table Global Biosimilars Sales by Application (2016-2025) (K MT)
Table Global Biosimilars Sales Share by Application (2016-2025)
Figure Global Sales Biosimilars Market Share by Application (2016-2025)
Figure Global Sales Biosimilars Market Share by Application (2016-2025)
Figure North America Biosimilars Sales Growth Rate 2016-2025 (K MT)
Figure North America Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table North America Biosimilars Sales by Countries (2016-2025) (K MT)
Table North America Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 North America Biosimilars Sales Market Share by Countries
Table North America Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table North America Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Biosimilars Revenue Market Share by Countries
Figure United States Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure United States Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Canada Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Mexico Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table North America Biosimilars Sales by Type (2016-2025) (K MT)
Table North America Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 North America Biosimilars Market Share by Type
Table North America Biosimilars Sales by Application (2016-2025) (K MT)
Table North America Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 North America Biosimilars Market Share by Application
Table North America Biosimilars Sales by Company (2016-2018) (K MT)
Table North America Biosimilars Sales Market Share by Company (2016-2018)
Figure North America Biosimilars Sales Market Share by Company in 2017
Figure Europe Biosimilars Sales Growth Rate 2016-2025 (K MT)
Figure Europe Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Biosimilars Sales by Countries (2016-2025) (K MT)
Table Europe Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Biosimilars Sales Market Share by Countries
Table Europe Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Europe Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Biosimilars Revenue Market Share by Countries
Figure Germany Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Germany Biosimilars Revenue Growth Rate (2016-2025) (K MT)
Figure France Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure France Biosimilars Revenue Growth Rate (2016-2025) (K MT)
Figure UK Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure UK Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Italy Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Russia Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Biosimilars Sales by Type (2016-2025) (K MT)
Table Europe Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Europe Biosimilars Market Share by Type
Table Europe Biosimilars Sales by Application (2016-2025) (K MT)
Table Europe Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Europe Biosimilars Market Share by Application
Table Europe Biosimilars Sales by Company (2016-2018) (K MT)
Table Europe Biosimilars Sales Market Share by Company (2016-2018)
Figure Europe Biosimilars Sales Market Share by Company in 2017
Figure Asia Pacific Biosimilars Sales Growth Rate 2016-2025 (K MT)
Figure Asia Pacific Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Biosimilars Sales by Countries (2016-2025) (K MT)
Table Asia Pacific Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Biosimilars Sales Market Share by Countries
Table Asia Pacific Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Biosimilars Revenue Market Share by Countries
Figure China Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure China Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Japan Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Korea Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure India Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure India Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Australia Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Indonesia Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Malaysia Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Philippines Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Thailand Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Vietnam Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Singapore Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Biosimilars Sales by Type (2016-2025) (K MT)
Table Asia Pacific Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Biosimilars Market Share by Type
Table Asia Pacific Biosimilars Sales by Application (2016-2025) (K MT)
Table Asia Pacific Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Biosimilars Market Share by Application
Table Asia Pacific Biosimilars Sales by Company (2016-2018) (K MT)
Table Asia Pacific Biosimilars Sales Market Share by Company (2016-2018)
Figure Asia Pacific Biosimilars Sales Market Share by Company in 2017
Figure Central & South America Biosimilars Sales Growth Rate 2016-2025 (K MT)
Figure Central & South America Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Biosimilars Sales by Countries (2016-2025) (K MT)
Table Central & South America Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Biosimilars Sales Market Share by Countries
Table Central & South America Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Biosimilars Revenue Market Share by Countries
Figure Brazil Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Brazil Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Argentina Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Biosimilars Sales by Type (2016-2025) (K MT)
Table Central & South America Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Biosimilars Market Share by Type
Table Central & South America Biosimilars Sales by Application (2016-2025) (K MT)
Table Central & South America Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Biosimilars Market Share by Application
Table Central & South America Biosimilars Sales by Company (2016-2018) (K MT)
Table Central & South America Biosimilars Sales Market Share by Company (2016-2018)
Figure Central & South America Biosimilars Sales Market Share by Company in 2017
Figure Middle East and Africa Biosimilars Sales Growth Rate 2016-2025 (K MT)
Figure Middle East and Africa Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Biosimilars Sales by Countries (2016-2025) (K MT)
Table Middle East and Africa Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Biosimilars Sales Market Share by Countries
Table Middle East and Africa Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Biosimilars Revenue Market Share by Countries
Figure GCC Countries Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure GCC Countries Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Turkey Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Egypt Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure South Africa Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Biosimilars Sales by Type (2016-2025) (K MT)
Table Middle East and Africa Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Biosimilars Market Share by Type
Table Middle East and Africa Biosimilars Sales by Application (2016-2025) (K MT)
Table Middle East and Africa Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Biosimilars Market Share by Application
Table Middle East and Africa Biosimilars Sales by Company (2016-2018) (K MT)
Table Middle East and Africa Biosimilars Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Biosimilars Sales Market Share by Company in 2017
Table Pfizer Company Details
Table Pfizer Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Sandoz International GmbH Company Details
Table Sandoz International GmbH Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Sandoz International GmbH Recent Development
Table Teva Pharmaceuticals Industries Company Details
Table Teva Pharmaceuticals Industries Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Teva Pharmaceuticals Industries Recent Development
Table Amgen Inc Company Details
Table Amgen Inc Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Amgen Inc Recent Development
Table Biocon Company Details
Table Biocon Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Biocon Recent Development
Table Dr. Reddys Laboratories Company Details
Table Dr. Reddys Laboratories Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Dr. Reddys Laboratories Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche Recent Development
Table Celltrion Company Details
Table Celltrion Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Celltrion Recent Development
Table Samsung Bioepis Company Details
Table Samsung Bioepis Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Samsung Bioepis Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Biosimilars Value Chain
Table Typical Suppliers of Key Biosimilars Raw Material
Table Biosimilars Customers List
Table Biosimilars Sales Channels
Table Biosimilars Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *